Chao‐Hung Hung

3.1k total citations
86 papers, 2.4k citations indexed

About

Chao‐Hung Hung is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Chao‐Hung Hung has authored 86 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Epidemiology, 78 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Chao‐Hung Hung's work include Liver Disease Diagnosis and Treatment (67 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (57 papers). Chao‐Hung Hung is often cited by papers focused on Liver Disease Diagnosis and Treatment (67 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (57 papers). Chao‐Hung Hung collaborates with scholars based in Taiwan, United States and Germany. Chao‐Hung Hung's co-authors include Jing‐Houng Wang, Chien‐Hung Chen, Sheng‐Nan Lu, Tsung‐Hui Hu, Chi‐Sin Changchien, Chuan–Mo Lee, Hung‐Da Tung, Chuan‐Mo Lee, Sheng‐Nan Lu and Chien‐Hung Chen and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer.

In The Last Decade

Chao‐Hung Hung

83 papers receiving 2.4k citations

Peers

Countries citing papers authored by Chao‐Hung Hung

Since Specialization

Citations

This map shows the geographic impact of Chao‐Hung Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Hung Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Hung Hung more than expected).

Fields of papers citing papers by Chao‐Hung Hung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao‐Hung Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Hung Hung. The network helps show where Chao‐Hung Hung may publish in the future.

Co-authorship network of co-authors of Chao‐Hung Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Chao‐Hung Hung. A scholar is included among the top collaborators of Chao‐Hung Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao‐Hung Hung. Chao‐Hung Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma 2026 ·Journal of the Formosan Medical Association ·(unknown), (unknown), Chao‐Hung Hung, (unknown), (unknown), Chao Huang, (unknown), (unknown)	0
2	Survival outcome with liver resection versus percutaneous radiofrequency ablation in patients with 2–3 cm single hepatocellular carcinoma 2025 ·Asian Journal of Surgery ·Yi‐Hao Yen, (unknown), Sheng‐Nan Lu, Tsung‐Hui Hu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen, Kwong‐Ming Kee, Chee‐Chien Yong, Weifeng Li, Chih‐Chi Wang, (unknown)	0
3	Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy. 2023 ·PubMed ·Hung‐Wei Wang, Chi-Yi Chen, Hsueh‐Chou Lai, Tsung‐Hui Hu, Wen‐Pang Su, Sheng‐Nan Lu, Chao‐Hung Hung, Po‐Heng Chuang, Jing‐Houng Wang, Chien‐Hung Chen, Cheng‐Yuan Peng	2
4	Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection 2021 ·Journal of Personalized Medicine ·Yen‐Po Lin, (unknown), Chih‐Chi Wang, Chih‐Che Lin, (unknown), (unknown), Pao‐Yuan Huang, Chao‐Hung Hung, (unknown), (unknown), (unknown), Ming‐Chao Tsai	18
5	The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients 2021 ·Journal of Viral Hepatitis ·Pao‐Yuan Huang, Jing‐Houng Wang, Chao‐Hung Hung, Sheng‐Nan Lu, Tsung‐Hui Hu, Chien‐Hung Chen	20
6	Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment 2019 ·PLoS ONE ·(unknown), Tsung‐Hui Hu, Chao‐Hung Hung, Jing‐Houng Wang, Sheng‐Nan Lu, Chien‐Hung Chen	27
7	Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients 2018 ·Digestive and Liver Disease ·Yi‐Hao Yen, Fang‐Ying Kuo, Kwong‐Ming Kee, Kuo‐Chin Chang, Ming‐Chao Tsai, Tsung‐Hui Hu, Sheng‐Nan Lu, Jing‐Houng Wang, Chao‐Hung Hung, Chien‐Hung Chen	2
8	Did AFP‐L3 save ultrasonography in community screening? 2018 ·The Kaohsiung Journal of Medical Sciences ·Chih‐Wei Yen, Yuan‐Hung Kuo, Jing‐Houng Wang, Kuo‐Chin Chang, Kwong‐Ming Kee, (unknown), Yi Chen, Lin‐San Tsai, Shu‐Chuan Chen, Chao‐Hung Hung, Sheng‐Nan Lu	5
9	Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy 2016 ·Journal of Antimicrobial Chemotherapy ·Cheng‐Kun Wu, Kuo‐Chin Chang, Chao‐Hung Hung, Po‐Lin Tseng, Sheng‐Nan Lu, Chien‐Hung Chen, Jing‐Houng Wang, Chuan–Mo Lee, Ming‐Chao Tsai, Ming‐Tsung Lin, Yi‐Hao Yen, Tsung‐Hui Hu	20
10	High Risk of Hepatitis B Virus Reactivation in Nucleos(t)ide Analogue-Induced Hepatitis B e Antigen Seroconverters Older Than 40 Years 2014 ·Digestive Diseases and Sciences ·(unknown), Chuan–Mo Lee, Chao‐Hung Hung, Jing‐Houng Wang, Tsung‐Hui Hu, Sheng‐Nan Lu, Chi‐Sin Changchien, Chien‐Hung Chen	8
11	Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation 2014 ·Journal of Hepatology ·Chien‐Hung Chen, Chih‐Lang Lin, Tsung‐Hui Hu, Chao‐Hung Hung, Po‐Lin Tseng, Jing‐Houng Wang, (unknown), Sheng‐Nan Lu, Rong‐Nan Chien, Chuan–Mo Lee	39
12	The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment 2014 ·Journal of Hepatology ·Chien‐Hung Chen, Sheng‐Nan Lu, Chao‐Hung Hung, Jing‐Houng Wang, Tsung‐Hui Hu, Chi‐Sin Changchien, Chuan–Mo Lee	120
13	Significance of Vitamin D Receptor Gene Polymorphisms for Risk of Hepatocellular Carcinoma in Chronic Hepatitis C 2014 ·Translational Oncology ·Chao‐Hung Hung, Yi‐Chun Chiu, Tsung‐Hui Hu, Chien‐Hung Chen, Sheng‐Nan Lu, (unknown), Jing‐Houng Wang, Chuan–Mo Lee	32
14	Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: A follow‐up study of an elderly cohort 2014 ·The Kaohsiung Journal of Medical Sciences ·Yuan‐Hung Kuo, (unknown), Jing‐Houng Wang, Pei‐Shan Tsai, (unknown), Chao‐Hung Hung, Sheng‐Nan Lu	9
15	Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations 2013 ·The Kaohsiung Journal of Medical Sciences ·Po‐Lin Tseng, Jing‐Houng Wang, Chao‐Hung Hung, Hung‐Da Tung, Tsung‐Ming Chen, (unknown), (unknown), Tsung‐Hui Hu, Chuan‐Mo Lee, Sheng‐Nan Lu	15
16	Neither Diabetes Mellitus nor Overweight Is a Risk Factor for Hepatocellular Carcinoma in a Dual HBV and HCV Endemic Area: Community Cross-Sectional and Case–Control Studies 2010 ·The American Journal of Gastroenterology ·Hung‐Da Tung, Jing‐Houng Wang, Po‐Lin Tseng, Chao‐Hung Hung, Kwong‐Ming Kee, Chien‐Hung Chen, Kuo‐Chin Chang, Chuan–Mo Lee, Chi‐Sin Changchien, (unknown), Sheng‐Nan Lu	41
17	Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance 2010 ·Journal of Hepatology ·Chien‐Hung Chen, Chuan–Mo Lee, Wei‐Chih Tung, Jing‐Houng Wang, Chao‐Hung Hung, Tsung‐Hui Hu, (unknown), Sheng‐Nan Lu, Chi‐Sin Changchien	22
18	Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients 2007 ·Gastroenterology ·Chien‐Hung Chen, Chao‐Hung Hung, Chuan–Mo Lee, Tsung‐Hui Hu, Jing‐Houng Wang, (unknown), Sheng‐Nan Lu, Chi‐Sin Changchien	187
19	Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants 2004 ·Journal of Hepatology ·Chien‐Hung Chen, Chuan–Mo Lee, Sheng‐Nan Lu, Jing‐Houng Wang, Hung‐Da Tung, Chao‐Hung Hung, Wei J. Chen, Chi‐Sin Changchien	41
20	CASE REPORT: Lamivudine Treatment for Recurrent Pancreatitis Associated with Reactivation of Chronic B Hepatitis 2002 ·Digestive Diseases and Sciences ·Chien‐Hung Chen, Chi‐Sin Changchien, Sheng‐Nan Lu, Jing‐Houng Wang, Chao‐Hung Hung, Chuan–Mo Lee	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact